Allarity Therapeutics, Inc. (ALLR)
Nasdaq: ALLR · Pharmaceutical Preparations · Boston, MA · filing with the SEC since 2021
Income statement, as filed
In thousands of US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Period ending | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 |
| Report filed | Mar 30, 2026 | Mar 31, 2025 | Mar 8, 2024 | Mar 13, 2023 | May 17, 2022 | · |
| Revenue | 320 | 0 | · | · | · | · |
| For lenders | ||||||
| Net interest income | · | · | · | · | -1,347 | · |
| Gross profit | · | · | · | -2,265 | · | · |
| Research and development | 6,601 | 6,096 | 7,103 | 6,930 | 14,196 | 4,218 |
| General and administrative | 6,324 | 11,442 | 10,026 | 9,962 | 12,360 | 4,101 |
| Total operating expenses | 12,925 | 27,241 | 17,129 | 34,463 | 26,556 | 8,319 |
| Operating income | -12,605 | -27,241 | -17,129 | -34,463 | -26,556 | -8,319 |
| Interest expense | 185 | 653 | 498 | 223r | 99 | 93 |
| Interest and investment income | 801 | 533 | 22 | 30 | · | · |
| Other income (expense), net | · | · | · | · | 41 | 1,900 |
| Total non-operating income (expense) | 1,374 | 2,345 | 5,311 | 16,884 | 41 | · |
| Income before income taxes | -11,231 | -24,896 | -11,818 | -17,579 | · | · |
| Income tax expense | 0 | -381 | 83 | -1,521 | 133 | 198 |
| Net income including non-controlling interests | · | · | · | -16,058 | -26,648 | -6,617 |
| Net income to non-controlling interests | · | · | · | · | · | -15 |
| Net income | -11,231 | -24,515 | -11,901 | -16,058 | -26,648 | -6,617 |
| Preferred dividends | · | · | 123 | 1,572 | · | · |
| Net income to common shareholders | -11,231 | -25,154 | -20,416 | -21,051r | -26,648 | -6,617 |
| Earnings per share, basic | -0.78 | -15.65 | -6,031.31r | -1,818,930.96rb | -3,449,208.00b | -1,671,096.00b |
| Earnings per share, diluted | · | · | -6,032.88b | -1,818,930.96rb | -3,449,208.00b | · |
| Weighted average shares, basic | 14,378,942 | 1,606,989 | 3,385r | 12rb | 8b | 4b |
| Weighted average shares, diluted | · | · | 3,386b | 12rb | 8b | 4b |
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.Share counts and per-share figures are on the newest report's basis, after the 1-for-588 reverse split.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Revenue what customers paid for what it sold
us-gaap:RevenueFromContractWithCustomerIncludingAssessedTaxNet interest income interest earned less interest paid
us-gaap:InterestIncomeExpenseNetGross profit revenue less the cost of what it sold
us-gaap:GrossProfitResearch and development spent on inventing what it sells next
us-gaap:ResearchAndDevelopmentExpenseGeneral and administrative the cost of running the company itself
us-gaap:GeneralAndAdministrativeExpenseTotal operating expenses the running costs together
us-gaap:OperatingExpensesOperating income profit from running the business, before interest and tax
us-gaap:OperatingIncomeLossInterest expense what its borrowing cost
us-gaap:InterestExpenseNonoperating
us-gaap:InterestExpense
us-gaap:InterestExpenseDebtInterest and investment income what its cash and investments earned
us-gaap:InvestmentIncomeInterestOther income (expense), net gains and costs outside the business
us-gaap:OtherNonoperatingIncomeExpenseTotal non-operating income (expense) everything outside the business, together
us-gaap:NonoperatingIncomeExpenseIncome before income taxes profit before tax
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestIncome tax expense tax charged on the period's profit
us-gaap:IncomeTaxExpenseBenefitNet income including non-controlling interests the whole group's profit, minority holders' share included
us-gaap:ProfitLossNet income to non-controlling interests the share that belongs to minority holders
us-gaap:NetIncomeLossAttributableToNoncontrollingInterestNet income the profit or loss that belongs to the company's shareholders
us-gaap:NetIncomeLossPreferred dividends paid to preferred holders before common shareholders
us-gaap:PreferredStockDividendsIncomeStatementImpactNet income to common shareholders what is left for common shareholders
us-gaap:NetIncomeLossAvailableToCommonStockholdersBasicEarnings per share, basic net income per share outstanding
us-gaap:EarningsPerShareBasicEarnings per share, diluted net income per share, counting every share that could be issued
us-gaap:EarningsPerShareDilutedWeighted average shares, basic the average count of shares outstanding
us-gaap:WeightedAverageNumberOfSharesOutstandingBasicWeighted average shares, diluted the average count with every share that could be issued
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding